Recombinant influenza vectors with a PolII promoter and ribozymes for vaccines and gene therapy
AssigneeWisconsin Alumni Research Foundation
InventorsYoshihiro Kawaoka, Stefan Hamm, Hideki Ebihara
Life of this patent
Estimating the term…
Abstract
The invention provides a composition useful to prepare influenza viruses, e.g., in the absence of helper virus, using vectors which include Po1II promoters and multiple ribozyme sequences.
Claims45
A composition comprising a plurality of orthomyxovirus vectors, comprising
- a) at least two vectors selected from a vector comprising a promoter operably linked to an influenza virus PA cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus PB1 cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus PB2 cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus HA cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus NP cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus NA cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus M cDNA linked to a transcription termination sequence, or a vector comprising a promoter operably linked to an influenza virus NS cDNA linked to a transcription termination sequence, wherein at least one vector comprises a RNA polymerase II promoter linked to a first ribozyme sequence linked to the viral cDNA linked to a second ribozyme sequence linked to the transcription termination sequence;
- and
- b) at least two vectors selected from a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PA, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PB1, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PB2, or a vector comprising a promoter operably linked to a DNA segment encoding influenza virus NP.
A composition comprising a plurality of orthomyxovirus vectors, comprising
- a) at least two vectors selected from a vector comprising a promoter operably linked to an influenza virus PA cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus PB1 cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus PB2 cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus HA cDNA linked to a transcription termination sequence, a vector comprising promoter operably linked to an influenza virus NP cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus cDNA for NB and NA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus M cDNA linked to a transcription termination sequence, or a vector comprising a promoter operably linked to an influenza virus NS cDNA linked to a transcription termination sequence, wherein at least one vector comprises a RNA polymerase II promoter linked to a first ribozyme sequence linked to the viral cDNA linked to a second ribozyme sequence linked to the transcription termination sequence;
- and
- b) at least two vectors selected from a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PA, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PB1, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PB2, or a vector comprising a promoter operably linked to a DNA segment encoding influenza virus NP.
A vector comprising a RNA polymerase II promoter linked to a first ribozyme sequence linked to an influenza virus cDNA linked to a second ribozyme sequence, wherein the influenza virus cDNA is an influenza virus PA cDNA, an influenza virus PB1 cDNA, an influenza virus PB2 cDNA, an influenza virus NP cDNA, an influenza virus HA cDNA, an influenza virus NA cDNA, an influenza virus M1 cDNA, an influenza virus M2 cDNA, an influenza virus NS2 cDNA, an influenza virus BM2 cDNA, or an influenza virus NS cDNA.
A method to prepare influenza virus, comprising contacting a cell with a vector comprising a promoter operably linked to an influenza virus PA cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus PB1 cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus PB2 cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus HA cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus NP cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus NA cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus M cDNA linked to a transcription termination sequence, and a vector comprising a promoter operably linked to an influenza virus NS cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PA, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PB1, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PB2, and a vector comprising a promoter operably linked to a DNA segment encoding influenza virus NP, so as to yield infectious virus, wherein the promoter in at least one vector comprising a viral cDNA comprises a RNA polymerase II promoter linked to a first ribozyme sequence linked to the viral cDNA linked to a second ribozyme sequence linked to a transcription termination sequence.
A method to prepare influenza virus, comprising contacting a cell with a vector comprising a promoter operably linked to an influenza virus PA cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus PB1 cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus PB2 cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus HA cDNA linked to a transcription termination sequence, a vector comprising promoter operably linked to an influenza virus NP cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus cDNA for NB and NA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus M cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to an influenza virus NS cDNA linked to a transcription termination sequence, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PA, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PB1, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus PB2, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus NP, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus HA, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus NA, a vector comprising a promoter operably linked to a DNA segment encoding influenza virus M, and a vector comprising a promoter operably linked to a DNA segment encoding influenza virus NS2, wherein at least one vector comprising a viral cDNA comprises a RNA polymerase II promoter linked to a first ribozyme sequence linked to the viral cDNA linked to a second ribozyme sequence linked to the transcription termination sequence.
Dependencies are inferred from the claim text.